Maud Janvier

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont et al. · The Lancet Oncology · 2011 · 530 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +8

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Jean‐Paul Fermand, Sandrine Katsahian, Marine Diviné et al. · Journal of Clinical Oncology · 2005 · 400 citations · Full text

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Christian Récher, Bertrand Coiffier, Corinne Haïoun et al. · The Lancet · 2011 · 356 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

Carole Soussain, Khê Hoang‐Xuan, Luc Taillandier et al. · Journal of Clinical Oncology · 2008 · 325 citations

Essential thrombocythemias. Clinical evolutionary and biological data

Sylvia Bellucci, Maud Janvier, G Tobelem et al. · Cancer · 1986 · 245 citations